title: Deep vein thrombosis associated with factor V inhibitor followed by immune thrombocytopenia.
authors.forename: Takakazu
authors.initials: T
authors.lastname: Higuchi
authors.forename: Takeshi
authors.initials: T
authors.lastname: Okamoto
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Kou
authors.forename: Tadashi
authors.initials: T
authors.lastname: Takeuchi
authors.forename: Ryosuke
authors.initials: R
authors.lastname: Koyamada
authors.forename: Sadamu
authors.initials: S
authors.lastname: Okada
mesh_terms: D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000032:analysis; D019774:Blood Coagulation Factor Inhibitors / Q000097:blood*; D002481:Cellulitis / Q000209:etiology; D003937:Diagnosis, Differential; D005165:Factor V / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D007866:Leg; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D011239:Prednisolone / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology* / Q000503:physiopathology; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000209:etiology*
chemical_list: D000893:Anti-Inflammatory Agents; D001323:Autoantibodies; D019774:Blood Coagulation Factor Inhibitors; D010975:Platelet Aggregation Inhibitors; D005165:Factor V; D011239:Prednisolone